In vivo CD4+ T-cell up-regulation and high dose side effects of refolded duck interleukin-2

Cytokine

Volumn 34, Issue 5-6, 2006, Pages 297-302

  Wang, Jinyong ^a   Qi, Jing ^a   Shen, Huigang ^a   Zhou, Jiyong ^a   Fang, Jie ^a   Chen, Hongxun ^a   Wang, Zhiping ^a   Li, Hongliang ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Immunophenotypic T cell; Lymphocyte proliferation; Monomer; Recombinant duck interleukin 2; Refolding; Toxicity

Indexed keywords

CONCANAVALIN A; MONOMER; RECOMBINANT INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DUCK; FOWL; IN VIVO STUDY; INTERSTITIAL PNEUMONIA; LYMPHOCYTE DEPLETION; NEPHRITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SPLEEN CELL; UPREGULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DUCKS; GENE EXPRESSION; IMMUNOPHENOTYPING; INTERLEUKIN-2; PROTEIN FOLDING; RECOMBINANT PROTEINS; UP-REGULATION;

AVES;

EID: 33747098481     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2006.06.006     Document Type: Article

References (28)

1. Blattman J.N., Grayson J.M., Wherry E.J., Kaech S.M., Smith K.A., and Ahmed R. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat Med 9 (2003) 40-47
2. Smith K. Interleukin 2 immunotherapy. In: Austen F., Burakoff S., Rosen F., and Strom T. (Eds). Therapeutic immunology (2001), Blackwell Science, Malden 240
3. Witzke O., Winterhagen T., Reinhardt W., Heemann U., Grosse-Wilde H., Kreuzfelder E., et al. Comparison between subcutaneous and intravenous interleukin-2 treatment in HIV disease. J Intern Med 244 (1998) 235-240
4. Palmer P.A., Vinke J., Evers P., Pourreau C., Oskam R., Roest G., et al. Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinoma. Eur J Cancer 28A (1992) 1038-1044
5. Chow Y.H., Huang W.L., Chi W.K., Chu Y.D., and Tao M.H. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol 71 (1997) 169-178
6. Geissler M., Gesien A., Tokushige K., and Wands J.R. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol 158 (1997) 1231-1237
7. Shimizu K., Fields R.C., Giedlin M., and Mule J.J. Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines. Proc Natl Acad Sci USA 96 (1999) 2268-2273
8. Schnetzler M., Oommen A., Nowak J.S., and Franklin R.M. Characterization of chicken T cell growth factor. Eur J Immunol 13 (1983) 560-566
9. Vainio O., Ratcliffe M.J., and Leanderson T. Chicken T-cell growth factor: use in the generation of a long-term cultured T-cell line and biochemical characterization. Scand J Immunol 23 (1986) 135-142
10. Schauenstein K., Kromer G., Hala K., Bock G., and Wick G. Chicken-activated-T-lymphocyte-antigen (CATLA) recognized by monoclonal antibody INN-CH 16 represents the IL-2 receptor. Dev Comp Immunol 12 (1988) 823-831
11. Sundick R.S., and Gill-Dixon C. A cloned chicken lymphokine homologous to both mammalian IL-2 and IL-15. J Immunol 159 (1997) 720-725
12. Kaiser P., and Mariani P. Promoter sequence, exon:intron structure, and synteny of genetic location show that a chicken cytokine with T-cell proliferative activity is IL2 and not IL15. Immunogenetics 49 (1999) 26-35
13. Stepaniak J.A., Shuster J.E., Hu W., and Sundick R.S. Production and in vitro characterization of recombinant chicken interleukin-2. J Interferon Cytokine Res 19 (1999) 515-526
14. Lawson S., Rothwell L., and Kaiser P. Turkey and chicken interleukin-2 cross-react in in vitro proliferation assays despite limited amino acid sequence identity. J Interferon Cytokine Res 20 (2000) 161-170
15. Arakawa T., Boone T., Davis J.M., and Kenney W.C. Structure of unfolded and refolded recombinant derived [Ala125]interleukin 2. Biochemistry 25 (1986) 8274-8277
16. Weir M.P., and Sparks J. Purification and renaturation of recombinant human interleukin-2. Biochem J 245 (1987) 85-91
17. Guisez Y., Demolder J., Mertens N., Raeymaekers A., Plaetinck G., Robbens J., Vandekerckhove J., Remaut E., and Fiers W. High-level expression, purification, and renaturation of recombinant murine interleukin-2 from Escherichia coli. Protein Expr Purif 4 (1993) 240-246
18. Wang Q.R., Ma L., Zhou M.Q., Liu N.Y., Jing S.R., Zou Q.M., and Wang X.N. Expression, refolding, purification, and bioactivity of recombinant bifunctional protein, hIL-2/GM-CSF. Protein Expr Purif 39 (2005) 131-136
19. Hilton L.S., Bean A.G., Kimpton W.G., and Lowenthal J.W. Interleukin-2 directly induces activation and proliferation of chicken T cells in vivo. J Interferon Cytokine Res 22 (2002) 755-763
20. Hulse D.J., and Romero C.H. Partial protection against infectious bursal disease virus through DNA-mediated vaccination with the VP2 capsid protein and chicken IL-2 genes. Vaccine 22 (2004) 1249-1259
21. Schultz U., Grgacic E., and Nassal M. Duck hepatitis B virus: an invaluable model system for HBV infection. Adv Virus Res 63 (2004) 1-70
22. Suzuki Y., and Nei M. Origin and evolution of influenza virus hemagglutinin genes. Mol Biol Evol 19 (2002) 501-509
23. Zhou J.Y., Wang J.Y., Chen J.G., Wu J.X., Gong H., Teng Q.Y., et al. Cloning, in vitro expression and bioactivity of duck interleukin-2. Mol Immunol 42 (2005) 589-598
24. Zhou J.Y., Chen J.G., Wang J.Y., Wu J.X., and Gong H. cDNA cloning and functional analysis of goose interleukin-2. Cytokine 30 (2005) 328-338
25. Brandhuber B.J., Boone T., Kenney W.C., and McKay D.B. Three-dimensional structure of interleukin-2. Science 238 (1987) 1707-1709
26. Jacobson E.L., Pilaro F., and Smith K.A. Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity. Proc Natl Acad Sci USA 93 (1996) 10405-10510
27. Smith K.A. Lowest dose interleukin-2 immunotherapy. Blood 81 (1993) 1414-1423
28. Hough R., Pratt G., and Rechsteiner M. Purification of two high molecular weight proteases from rabbit reticulocyte lysate. J Biol Chem 262 (1987) 8303-8313